Personal CFO Solutions LLC Sells 379 Shares of STERIS plc (NYSE:STE)

Personal CFO Solutions LLC trimmed its stake in STERIS plc (NYSE:STE) by 9.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,656 shares of the medical equipment provider’s stock after selling 379 shares during the period. Personal CFO Solutions LLC’s holdings in STERIS were worth $751,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its position in shares of STERIS by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock worth $556,786,000 after buying an additional 17,007 shares during the period. Principal Financial Group Inc. boosted its stake in STERIS by 0.5% during the 4th quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider’s stock worth $230,160,000 after acquiring an additional 5,419 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of STERIS during the fourth quarter worth $223,987,000. Franklin Resources Inc. raised its holdings in STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in STERIS by 3.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider’s stock worth $117,136,000 after purchasing an additional 18,384 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Up 0.3 %

Shares of STE stock opened at $233.02 on Monday. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The stock’s fifty day simple moving average is $216.96 and its 200 day simple moving average is $222.70.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, sell-side analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.98%. STERIS’s dividend payout ratio (DPR) is 48.41%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on STE shares. Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reissued an “overweight” rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.